pargyline has been researched along with Brain Ischemia in 1 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Brain Ischemia: Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strasser, A | 1 |
| Yasuma, Y | 1 |
| McCarron, RM | 1 |
| Ishii, H | 1 |
| Stanimirovic, D | 1 |
| Spatz, M | 1 |
1 other study available for pargyline and Brain Ischemia
| Article | Year |
|---|---|
Effect of nitro-L-arginine on cerebral blood flow and monoamine metabolism during ischemia/reperfusion in the mongolian gerbil.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Arginine; Biogenic Monoamines; Body T | 1994 |